Pharma too not immune to meltdown
The global meltdown woes have even reached one of the most insulated sectors-Pharma. However, even as global markets are non-growing for many Indian players, domestic markets prove to be an anchor with steady growth at a volatile time. The Indian drug makers were the stars of 2008 in the stock market driven by a healthy local demand despite economic turbulence.
